The Journal of allergy and clinical immunology
Context-specific genetic effects inform endotypes and treatment in asthma.
PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.
High airway thymic stromal lymphopoietin in asthma is associated with type 2 inflammation, mucus plugging, and airway remodeling.
Asthma treatment response modified by fine particulate matter, nitrogen dioxide, and ozone among Black children: A reanalysis of the AsthmaNet Best African American Response to Asthma Drugs trial.
The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument.
Mitochondrial DNA Copy Number Variation in Asthma Risk, Severity, and Exacerbations.
Investigation of LTF mRNA expression levels as an anti-T2 asthma biomarker.
Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma.
Early-life Nasal Microbiota Dynamics Relate to Longitudinal Respiratory Phenotypes in Urban Children.
Increasing wildfire smoke from the climate crisis: Impacts on asthma and allergies.
